Federation des caisses Desjardins du Quebec’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$101K Buy
2,072
+250
+14% +$12.2K ﹤0.01% 1368
2025
Q1
$62K Sell
1,822
-41
-2% -$1.4K ﹤0.01% 1427
2024
Q4
$73.3K Buy
1,863
+882
+90% +$34.7K ﹤0.01% 1334
2024
Q3
$46.1K Sell
981
-57
-5% -$2.68K ﹤0.01% 1427
2024
Q2
$56.1K Buy
1,038
+7
+0.7% +$378 ﹤0.01% 1368
2024
Q1
$70.3K Buy
1,031
+231
+29% +$15.7K ﹤0.01% 1317
2023
Q4
$50.1K Sell
800
-101
-11% -$6.32K ﹤0.01% 1308
2023
Q3
$40.9K Hold
901
﹤0.01% 1365
2023
Q2
$50.6K Sell
901
-42
-4% -$2.36K ﹤0.01% 1324
2023
Q1
$42.7K Buy
943
+425
+82% +$19.2K ﹤0.01% 1370
2022
Q4
$21.1K Sell
518
-325
-39% -$13.2K ﹤0.01% 1667
2022
Q3
$55.1K Buy
843
+100
+13% +$6.54K ﹤0.01% 1488
2022
Q2
$45.2K Sell
743
-85
-10% -$5.17K ﹤0.01% 1544
2022
Q1
$52K Sell
828
-155
-16% -$9.73K ﹤0.01% 1573
2021
Q4
$74.5K Sell
983
-55
-5% -$4.17K ﹤0.01% 1474
2021
Q3
$116K Sell
1,038
-220
-17% -$24.6K ﹤0.01% 1350
2021
Q2
$204K Sell
1,258
-31
-2% -$5.02K ﹤0.01% 1178
2021
Q1
$157K Buy
1,289
+179
+16% +$21.8K ﹤0.01% 1190
2020
Q4
$170K Buy
1,110
+107
+11% +$16.4K ﹤0.01% 1103
2020
Q3
$83.9K Sell
1,003
-3,298
-77% -$276K ﹤0.01% 1109
2020
Q2
$317K Sell
4,301
-20,737
-83% -$1.53M ﹤0.01% 738
2020
Q1
$1.07M Buy
25,038
+23,558
+1,592% +$1.01M 0.02% 504
2019
Q4
$90.1K Sell
1,480
-90
-6% -$5.48K ﹤0.01% 1350
2019
Q3
$64.4K Hold
1,570
﹤0.01% 1408
2019
Q2
$73.9K Sell
1,570
-30
-2% -$1.41K ﹤0.01% 1376
2019
Q1
$57.2K Sell
1,600
-100
-6% -$3.57K ﹤0.01% 1286
2018
Q4
$48.6K Sell
1,700
-2,630
-61% -$75.1K ﹤0.01% 1290
2018
Q3
$192K Sell
4,330
-300
-6% -$13.3K ﹤0.01% 1032
2018
Q2
$272K Buy
4,630
+3,530
+321% +$207K ﹤0.01% 973
2018
Q1
$50.3K Buy
1,100
+850
+340% +$38.9K ﹤0.01% 1326
2017
Q4
$5.87K Hold
250
﹤0.01% 1841
2017
Q3
$4.47K Sell
250
-550
-69% -$9.83K ﹤0.01% 1844
2017
Q2
$12.8K Buy
800
+152
+23% +$2.44K ﹤0.01% 1673
2017
Q1
$14.1K Buy
+648
New +$14.1K ﹤0.01% 1363